Sort
23,748 grants matching “melanoma”
Functional B7-H1 expressed by T cells
$397,500Haidong Dong · Mayo Clinic Rochester · R01 · FY2014 · AI
Functional B7-H1 expressed by T cells
$397,500Haidong Dong · Mayo Clinic Rochester · R01 · FY2018 · AI
Functional B7-H1 expressed by T cells
$397,500Haidong Dong · Mayo Clinic Rochester · R01 · FY2015 · AI
Functional B7-H1 expressed by T cells
$397,500Haidong Dong · Mayo Clinic Rochester · R01 · FY2016 · AI
Functional B7-H1 expressed by T cells
$397,500Haidong Dong · Mayo Clinic Rochester · R01 · FY2017 · AI
ADHESIVE SIGNALING BY PLATELET BETA-3 INTEGRINS
$397,472Scripps Research Institute · R01 · FY2000 · HL
PROTEAN-CR: Proteomics Toolkit for Ensemble Analysis in Cancer Research
$397,442Lydia E. Kavraki · Rice University · U01 · FY2022 · CA
The Inhibition of HNSCC Growth and Metastasis by Targeting KDM4A
$397,373Cun-Yu Wang · University Of California Los Angeles · R01 · FY2021 · DE
The Inhibition of HNSCC Growth and Metastasis by Targeting KDM4A
$397,371Cun-Yu Wang · University Of California Los Angeles · R01 · FY2023 · DE
Project 2: Mechanochemical Mechanisms and Vulnerabilities of Individual and Collective Organ-Preferential Metastasis In Vivo
$397,281Stuart S Levine · Massachusetts Institute Of Technology · U54 · FY2025 · CA
TLR5 signaling as a conserved mechanism of impaired anti-tumor immunity
$397,110Melanie R Rutkowski · University Of Virginia · R01 · FY2024 · CA
B cell depletion to prevent autoimmunity
$397,099Kavita Dhodapkar · Emory University · R01 · FY2022 · AR
Applying nanosecond pulse electric fields to treat skin cancer
$397,073Richard Lee Nuccitelli · Bioelectromed Corporation · R01 · FY2011 · CA
Identifying Therapeutic Targets for Stage III Melanoma
$397,059Anand K Ganesan · University Of California-Irvine · R01 · FY2024 · CA
Mechanisms of liver metastasis and associated resistance to immunotherapy
$397,013Benjamin Izar · Columbia University Health Sciences · R37 · FY2023 · CA
Glycolipid Interactions in Melanoma Adhesion
$397,000Amit Basu · Brown University · · FY2005 · MPS
MULTI-EPITOPE MELANOMA VACCINES FOR CD4 AND CD8 T-CELLS
$396,912Craig Lee Slingluff · University Of Virginia · R01 · FY2009 · CA
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis
$396,901Wei Dai · New York University School Of Medicine · R01 · FY2014 · ES
The lymph node microenvionment in tumor metastasis
$396,852Judith A. Varner · University Of California, San Diego · R01 · FY2009 · CA
Project 1 - Siah 1 in ER and Mitochondrial Function and Homeostasis in Melanoma
$396,832Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2018 · CA
Project 1 - Siah 1 in ER and Mitochondrial Function and Homeostasis in Melanoma
$396,832Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2020 · CA
MOUSE MODELS FOR HUMAN CANCER
$396,760University Of Wisconsin Madison · U01 · FY2002 · CA
The Unique Roles of Tumor-Specific Th9 Cells for Solid Tumor Eradication
$396,737Yong Lu · Methodist Hospital Research Institute · R01 · FY2025 · CA
B cell depletion to prevent autoimmunity
$396,705Kavita Dhodapkar · Emory University · R01 · FY2021 · AR
Cindi Study: A Phase II Clinical Trial to Combine CD24Fc with Ipilimumab and Nivolumab to Decrease Immune Related Adverse Events (irAE)
$396,664Pan Zheng · Oncoimmune, Inc. · R44 · FY2020 · CA